| scholarly article | Q13442814 |
| P50 | author | Martin Hausmann | Q73799368 |
| P2093 | author name string | M Fried | |
| G Rogler | |||
| C Lutz | |||
| M Mozaffari | |||
| B L McRae | |||
| C L Graff | |||
| M Caj | |||
| P Cippà | |||
| V Tosevski | |||
| P2860 | cites work | Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis | Q74463009 |
| Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway | Q77061247 | ||
| Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice | Q77774791 | ||
| The BH3-mimetic ABT-737 inhibits allogeneic immune responses | Q84201771 | ||
| Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity | Q28138855 | ||
| Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis | Q28589263 | ||
| An inhibitor of Bcl-2 family proteins induces regression of solid tumours | Q29547595 | ||
| Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease | Q33398808 | ||
| Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer | Q33400716 | ||
| Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells | Q34039998 | ||
| Bcl-2-regulated cell death signalling in the prevention of autoimmunity | Q34545377 | ||
| Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models | Q34783875 | ||
| The role of apoptosis in rheumatoid arthritis | Q35156041 | ||
| Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids | Q35209017 | ||
| Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease | Q35364122 | ||
| Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease. | Q35596974 | ||
| T- and B-cell abnormalities in systemic lupus erythematosus | Q36161314 | ||
| Role of Bim and other Bcl-2 family members in autoimmune and degenerative diseases | Q36361205 | ||
| Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels | Q36946423 | ||
| Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1. | Q37451892 | ||
| The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management | Q37814541 | ||
| Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management | Q38049776 | ||
| CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes | Q39744964 | ||
| Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. | Q40717909 | ||
| Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. | Q40943884 | ||
| Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. | Q41941349 | ||
| In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. | Q42003082 | ||
| The anti-apoptotic Bcl-2 family member Mcl-1 promotes T lymphocyte survival at multiple stages | Q42091535 | ||
| The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs | Q43206184 | ||
| Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease | Q44569723 | ||
| Bystander virus infection prolongs activated T cell survival | Q45750055 | ||
| The Bcl-2 family antagonist ABT-737 significantly inhibits multiple animal models of autoimmunity. | Q45983884 | ||
| Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines | Q46333985 | ||
| Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. | Q49073992 | ||
| Impaired removal of Vβ8(+) lymphocytes aggravates colitis in mice deficient for B cell lymphoma-2-interacting mediator of cell death (Bim). | Q50998106 | ||
| The origin of anti-nuclear antibodies in bcl-2 transgenic mice. | Q52170468 | ||
| Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages. | Q54351753 | ||
| Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo | Q57079498 | ||
| Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment | Q57119828 | ||
| Increased proportion of CD16+ NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment | Q57971839 | ||
| Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity | Q73397066 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 343-356 | |
| P577 | publication date | 2015-05-19 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression. | |
| P478 | volume | 181 |
| Q88624173 | BCL-2 levels do not predict azathioprine treatment response in inflammatory bowel disease, but inhibition induces lymphocyte apoptosis and ameliorates colitis in mice |
| Q39277476 | Dying to protect: cell death and the control of T-cell homeostasis. |
| Q92493786 | Imbalance of Controlled Death in Peripheral Blood Lymphocytes in Crohn's Disease and Ulcerative Colitis |
| Q48104766 | Isolation and high-dimensional phenotyping of gastrointestinal immune cells. |
| Q37521403 | Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation |
| Q39290025 | Pharmacological modulation of cell death in organ transplantation. |
| Q41203716 | The Extracts of Morinda officinalis and Its Hairy Roots Attenuate Dextran Sodium Sulfate-Induced Chronic Ulcerative Colitis in Mice by Regulating Inflammation and Lymphocyte Apoptosis |
| Q27324510 | Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice |
| Q41092619 | αMSH prevents ROS-induced apoptosis by inhibiting Foxo1/mTORC2 in mice adipose tissue |
Search more.